Biochemical regulators in cardiac hypertrophy.
In recent years research has shown that muscle is capable of reacting to mechanical stimuli by altering biochemical processes. Myocardium is probably the source of a biochemical factor, or factors which activate myocardial protein synthesis. In experimentally induced cardiac hypertrophy adaptive alterations have been shown to occur not only in the adrenal medulla but also in the adrenal cortex. Finally, detection of cross reactivity between digitalis glycosides and a number of steroid hormones has succeeded. We assume that such cross reactivity indicates the existence of an endogenic factor of steroid character, which is produced in the adrenal gland and functions as an endogenic cardiotonic agent. During experimental cardiac hypertrophy its synthesis is possibly increased. We propose the term "endocardin" or "endocardiotonin" for this agent.
D000302:Adrenal Cortex / Q000503:physiopathology; D000313:Adrenal Medulla / Q000503:physiopathology; D000818:Animals; D002301:Cardiac Glycosides / Q000494:pharmacology; D006332:Cardiomegaly / Q000378:metabolism*; D055598:Chemical Phenomena; D002621:Chemistry; D005938:Glucocorticoids / Q000502:physiology; D006801:Humans; D009206:Myocardium / Q000378:metabolism*; D009929:Organ Size; D014176:Protein Biosynthesis; D011817:Rabbits; D051381:Rats; D013314:Stress, Mechanical
D002301:Cardiac Glycosides; D005938:Glucocorticoids